Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Molinaro

Showing results (271-280 of 336) with videos related to

Pageof 34
Sort By:
NPJ Precision Oncology|November 18, 2024
Methylation cytometric pretreatment blood immune profiles with tumor mutation burden as prognostic indicators for survival outcomes in head and neck cancer patients on anti-PD-1 therapyZe Zhang, Kartik Sehgal, Keisuke Shirai, et al.
Oncogene|December 2, 2010
A Variant in a MicroRNA complementary site in the 3' UTR of the KIT oncogene increases risk of acral melanomaS E Godshalk, T Paranjape, S Nallur, et al.
Neuro-Oncology Practice|September 27, 2019
Reirradiation of recurrent high-grade glioma and development of prognostic scores for progression and survivalChristopher H Chapman, Jared H Hara, Annette M Molinaro, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 5, 2022
CXCL14 Promotes a Robust Brain Tumor-Associated Immune Response in GliomaAnupam Kumar, Esraa Mohamed, Schuyler Tong, et al.
Cancer Chemotherapy and Pharmacology|February 25, 2017
A phase 1 trial of intravenous liposomal irinotecan in patients with recurrent high-grade gliomaJennifer L Clarke, Annette M Molinaro, Juan R Cabrera, et al.
Cancer Discovery|February 1, 2015
The genetics of splicing in neuroblastomaJustin Chen, Christopher S Hackett, Shile Zhang, et al.
Journal of Neuro-Oncology|October 2, 2017
Germline polymorphisms in myeloid-associated genes are not associated with survival in glioma patientsDaniel I Jacobs, Yanhong Liu, Konrad Gabrusiewicz, et al.
Neuro-Oncology|April 23, 2020
Recurrent tumor and treatment-induced effects have different MR signatures in contrast enhancing and non-enhancing lesions of high-grade gliomasJulia Cluceru, Sarah J Nelson, Qiuting Wen, et al.
Molecular Cell|June 13, 2025
The immortality mechanism of TERT promoter mutant cancers is self-reinforcing and reversibleNicholas O Stevers, Somang Kim, Jimmy Bo Yuan, et al.
Research Square|January 18, 2024
Enrichment of a neutrophil-like monocyte transcriptional state in glioblastoma myeloid suppressor cellsJ K Wiencke, Emily Nissen, Devin C Koestler, et al.
Pageof 34

Showing results (271-280 of 336) with videos related to

Sort By:
Pageof 34
NPJ Precision Oncology|November 18, 2024
Methylation cytometric pretreatment blood immune profiles with tumor mutation burden as prognostic indicators for survival outcomes in head and neck cancer patients on anti-PD-1 therapyZe Zhang, Kartik Sehgal, Keisuke Shirai, et al.
Oncogene|December 2, 2010
A Variant in a MicroRNA complementary site in the 3' UTR of the KIT oncogene increases risk of acral melanomaS E Godshalk, T Paranjape, S Nallur, et al.
Neuro-Oncology Practice|September 27, 2019
Reirradiation of recurrent high-grade glioma and development of prognostic scores for progression and survivalChristopher H Chapman, Jared H Hara, Annette M Molinaro, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 5, 2022
CXCL14 Promotes a Robust Brain Tumor-Associated Immune Response in GliomaAnupam Kumar, Esraa Mohamed, Schuyler Tong, et al.
Cancer Chemotherapy and Pharmacology|February 25, 2017
A phase 1 trial of intravenous liposomal irinotecan in patients with recurrent high-grade gliomaJennifer L Clarke, Annette M Molinaro, Juan R Cabrera, et al.
Cancer Discovery|February 1, 2015
The genetics of splicing in neuroblastomaJustin Chen, Christopher S Hackett, Shile Zhang, et al.
Journal of Neuro-Oncology|October 2, 2017
Germline polymorphisms in myeloid-associated genes are not associated with survival in glioma patientsDaniel I Jacobs, Yanhong Liu, Konrad Gabrusiewicz, et al.
Neuro-Oncology|April 23, 2020
Recurrent tumor and treatment-induced effects have different MR signatures in contrast enhancing and non-enhancing lesions of high-grade gliomasJulia Cluceru, Sarah J Nelson, Qiuting Wen, et al.
Molecular Cell|June 13, 2025
The immortality mechanism of TERT promoter mutant cancers is self-reinforcing and reversibleNicholas O Stevers, Somang Kim, Jimmy Bo Yuan, et al.
Research Square|January 18, 2024
Enrichment of a neutrophil-like monocyte transcriptional state in glioblastoma myeloid suppressor cellsJ K Wiencke, Emily Nissen, Devin C Koestler, et al.
Pageof 34